These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Beneficial effects of Nrf2 overexpression in a mouse model of Alexander disease. LaPash Daniels CM, Austin EV, Rockney DE, Jacka EM, Hagemann TL, Johnson DA, Johnson JA, Messing A. J Neurosci; 2012 Aug 01; 32(31):10507-15. PubMed ID: 22855800 [Abstract] [Full Text] [Related]
8. STAT3 Drives GFAP Accumulation and Astrocyte Pathology in a Mouse Model of Alexander Disease. Hagemann TL, Coyne S, Levin A, Wang L, Feany MB, Messing A. Cells; 2023 Mar 23; 12(7):. PubMed ID: 37048051 [Abstract] [Full Text] [Related]
10. Aberrant astrocyte Ca2+ signals "AxCa signals" exacerbate pathological alterations in an Alexander disease model. Saito K, Shigetomi E, Yasuda R, Sato R, Nakano M, Tashiro K, Tanaka KF, Ikenaka K, Mikoshiba K, Mizuta I, Yoshida T, Nakagawa M, Mizuno T, Koizumi S. Glia; 2018 May 23; 66(5):1053-1067. PubMed ID: 29383757 [Abstract] [Full Text] [Related]
12. Astrocyte pathology in Alexander disease causes a marked inflammatory environment. Olabarria M, Putilina M, Riemer EC, Goldman JE. Acta Neuropathol; 2015 Oct 23; 130(4):469-86. PubMed ID: 26296699 [Abstract] [Full Text] [Related]
13. GFAP Mutations in Astrocytes Impair Oligodendrocyte Progenitor Proliferation and Myelination in an hiPSC Model of Alexander Disease. Li L, Tian E, Chen X, Chao J, Klein J, Qu Q, Sun G, Sun G, Huang Y, Warden CD, Ye P, Feng L, Li X, Cui Q, Sultan A, Douvaras P, Fossati V, Sanjana NE, Riggs AD, Shi Y. Cell Stem Cell; 2018 Aug 02; 23(2):239-251.e6. PubMed ID: 30075130 [Abstract] [Full Text] [Related]
14. Dynamics of mutated GFAP aggregates revealed by real-time imaging of an astrocyte model of Alexander disease. Mignot C, Delarasse C, Escaich S, Della Gaspera B, Noé E, Colucci-Guyon E, Babinet C, Pekny M, Vicart P, Boespflug-Tanguy O, Dautigny A, Rodriguez D, Pham-Dinh D. Exp Cell Res; 2007 Aug 01; 313(13):2766-79. PubMed ID: 17604020 [Abstract] [Full Text] [Related]
15. Genetic ablation of Nrf2/antioxidant response pathway in Alexander disease mice reduces hippocampal gliosis but does not impact survival. Hagemann TL, Jobe EM, Messing A. PLoS One; 2012 Aug 01; 7(5):e37304. PubMed ID: 22693571 [Abstract] [Full Text] [Related]
16. Plectin regulates the organization of glial fibrillary acidic protein in Alexander disease. Tian R, Gregor M, Wiche G, Goldman JE. Am J Pathol; 2006 Mar 01; 168(3):888-97. PubMed ID: 16507904 [Abstract] [Full Text] [Related]
17. GFAP expression as an indicator of disease severity in mouse models of Alexander disease. Jany PL, Hagemann TL, Messing A. ASN Neuro; 2013 Mar 01; 5(1):e00109. PubMed ID: 23432455 [Abstract] [Full Text] [Related]
18. Microglia sense astrocyte dysfunction and prevent disease progression in an Alexander disease model. Saito K, Shigetomi E, Shinozaki Y, Kobayashi K, Parajuli B, Kubota Y, Sakai K, Miyakawa M, Horiuchi H, Nabekura J, Koizumi S. Brain; 2024 Feb 01; 147(2):698-716. PubMed ID: 37955589 [Abstract] [Full Text] [Related]
19. Elevated GFAP isoform expression promotes protein aggregation and compromises astrocyte function. Lin NH, Yang AW, Chang CH, Perng MD. FASEB J; 2021 May 01; 35(5):e21614. PubMed ID: 33908669 [Abstract] [Full Text] [Related]